BCDA — Biocardia Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

Trend Edge Setup Score

Trend Edge rates BCDA Bearish with a Setup Score of 38, net conviction 35, actionability 42. How the Setup Score works →

Total Setup Score38
Directional BiasBearish
Net Conviction35
Actionability42 (in range)

Key signals behind this score

About Biocardia Inc

BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. The company's lead product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clinical trial for the treatment of ischemic heart failure with reduced ejection fraction and refractory angina resulting from chronic myocardial ischemia. Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$0.90
Market Cap$13.5M
Float12.3M
Shares Outstanding15.1M
Price/Sales (TTM)2,520.59
vs. Analyst Target+1622.2% to analyst PT
Dividend RateNone
Analyst Target Price$15.50 (2 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $145,000 -$15.0M $141,000 -$14.4M
2021 $1.0M -$12.6M $375,000 -$12.6M
2022 $1.4M -$11.9M -$10.5M -$11.8M
2023 $477,000 -$11.6M -$7.2M -$11.5M
2024 $58,000 -$7.9M -$4.3M -$7.9M
2025 N/A -$8.2M -$505,000 -$7.7M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Sep 2025 N/A -$1.5M
Dec 2025 N/A -$2.0M
Mar 2026 N/A -$2.3M
Jun 2026 N/A -$1.6M

Ownership & Float

Insider Ownership17.9%
Institutional Ownership14.0%
Short Float5.5%

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$0.98Near-term / short-term trend
Weekly40-Week SMA$1.05Medium-term trend
Weekly80-Week SMA$1.39Cyclical trend (business cycle)
Weekly200-Week SMA$7.31Secular trend (multi-year)
Monthly10-Month SMA$1.05Near-term monthly trend
Monthly20-Month SMA$1.43Medium-term monthly trend
Monthly40-Month SMA$3.23Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$1.90 resistance 5.27x 13 months ago

Historical Earnings Reactions (99 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.08% 0.00% 28.28% 48.51% -38.82%
1 Day -0.04% 0.00% 27.27% 48.51% -38.82%
1 Week 9.90% 0.00% 40.40% 575.00% -60.71%
2 Weeks 10.84% 0.00% 40.40% 525.00% -64.29%
1 Month 9.64% -4.13% 36.36% 675.00% -51.65%

Next earnings: November 11, 2026 (1 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan5.1%53.3%30
Feb-1.7%36.7%30
Mar-6.0%26.7%30
Apr6.9%33.3%30
May-2.2%40.0%30
Jun2.2%43.3%30
Jul21.0%43.3%30
Aug-9.1%16.7%30
Sep17.7%33.3%30
Oct-2.9%36.7%30
Nov4.0%41.4%29
Dec-1.7%33.3%30

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.24% 24.6% 1418
Tuesday 0.46% 26.5% 1549
Wednesday 0.22% 25.7% 1547
Thursday 0.56% 25.8% 1518
Friday 0.73% 27.2% 1510

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 14.0%

Insider Transactions — Smart Summary

Total insider ownership: 17.9%

12-Month Insider Activity Summary

Total Filings23
Net Value+$66,081.46
Net Shares Change177,100
% of Float1.4%
C-Suite Filings22
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
Altman Peter President and CEO +$26,386.15 10 10 buy

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-10-20 Altman Peter President and CEO +$475 Transaction at $0.95, now -5.3%
2026-09-30 Altman Peter President and CEO +$1,030 Transaction at $1.03, now -12.6%
2026-09-23 Altman Peter President and CEO +$1,995 Transaction at $1.05, now -14.3%
2026-09-04 Altman Peter President and CEO +$872 Transaction at $1.09, now -17.4%
2026-08-18 Altman Peter President and CEO +$5,022 Transaction at $0.93, now -3.2%
2026-08-13 Altman Peter President and CEO +$1,748 Transaction at $0.92, now -2.2%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Biocardia Inc (BCDA) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for BCDA on Trend Edge →